Cargando…
Effect of Pioglitazone on the Course of New-Onset Type 1 Diabetes Mellitus
Objective: Type 1 diabetes mellitus (T1DM) is caused by insulin deficiency resulting from progressive destruction of β cells. The histological hallmark of the diabetic islet is mononuclear cell infiltration. Thiazolidinediones (TZDs) activate PPARg and enhance the actions of insulin. Studies in non-...
Autores principales: | Tafuri, Kimberly Sue, Godil, Mushtaq Ahmed, Lane, Andrew Harry, Wilson, Thomas Allen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890222/ https://www.ncbi.nlm.nih.gov/pubmed/24379032 http://dx.doi.org/10.4274/Jcrpe.981 |
Ejemplares similares
-
Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014) -
Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
por: Park, Jong Suk, et al.
Publicado: (2011) -
The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus
por: Mori, Hiroko, et al.
Publicado: (2017) -
Does Diabetes Mellitus Alter the Onset and Clinical Course of Vascular Dementia?
por: Murthy, Santosh B., et al.
Publicado: (2010) -
Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
por: Kadowaki, Takashi, et al.
Publicado: (2013)